MedPath

Validation of an Allergic Rhinitis Control Test in Teenagers

Not Applicable
Conditions
Allergic Rhinitis
Interventions
Other: Self questionnaire for allergic rhinitis control
Registration Number
NCT02818153
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired quality of life. Patients often report a poor level of satisfaction with the effectiveness of their treatment and are always looking for more drug combinations to improve their symptom. Several tools exist for assessing control of allergic rhinitis, but none has been validated in adolescents or in children. A study conducted in 2008, resulted in the validation of a self-administered control test of allergic rhinitsis (ARCT) in patients from 12 years of age. However, this study included only 67 adolescents aged 12 to 17 years old and lacked power.

In this new study,the investigators propose, following exactly the same procedure as the pilot study of 2008, to confirme the validation of unmodified Adult questionnaire in adolescents 12 to 17 years inclusive.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients aged 12 to 17 years old, consulting a practitioner for an allergic rhinitis
  • parents formulated their study participation agreement by signing the consent form.
Exclusion Criteria
  • Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatement.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
questionnaire for allergic rhinitis controlSelf questionnaire for allergic rhinitis controlTeenagers from 12 to 17 years old who complete a Self questionnaire regarding allergic rhinitis control during the consultation and after 15 days
Primary Outcome Measures
NameTimeMethod
Score of the allergic rhinitis control self questionnaire in teenagers from 12 to 17 years old.15 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University hospital of Montpellier

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath